Benjamin Greene

University of Alabama at Birmingham

Papers

1

Total Citations

15

H-Index

1

About

Benjamin Greene is a leading surgical oncologist whose research focuses on advancing precision surgery for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on integrating molecular imaging with robotic surgery to improve tumor visualization and resection accuracy. In his landmark 2024 study, Greene reported interim Phase II results using Panitumumab-IRDye800CW during transoral robotic surgery (TORS), demonstrating how targeted fluorescence imaging can overcome the tactile limitations of robotic approaches by highlighting cancerous tissue in real time. This work has already garnered 15 citations and represents a critical step toward reducing positive margins and preserving healthy tissue in OPSCC patients. Greene’s research addresses the rising incidence of HPV-related oropharyngeal cancers while improving functional outcomes through minimally invasive techniques. His innovative combination of antibody-dye conjugates with robotic platforms positions him at the forefront of image-guided oncologic surgery, offering patients more precise, less morbid treatment options.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer
15 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University of Alabama at Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago